logo
Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers

Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers

Business Wire5 days ago

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced the successful transition of 123 out of 132 newly awarded plasma donation centers. The remaining nine centers are on track to go live in the third quarter of 2025.
We delivered a seamless experience for center staff, leadership teams and donors—without disruption—setting a new benchmark for speed and precision in the industry.
Share
The onboarding of 123 centers was completed in just one week – significantly ahead of schedule – demonstrating Paysign's operational agility, platform scalability and executional discipline.
'Successfully transitioning this volume of centers in a single week is a testament to the strength of our platform, the rigor of our processes and the exceptional capabilities of our team,' said Mark Newcomer, President and CEO of Paysign. 'We delivered a seamless experience for center staff, leadership teams and donors—without disruption—setting a new benchmark for speed and precision in the industry. The addition of these centers represents a pivotal return to revenue growth for this business unit. This, combined with the continuing exceptional growth of our patient affordability business, gives us great confidence in Paysign's forward momentum.'
This achievement reinforces Paysign's strategic value to plasma collection organizations seeking reliable, scalable and compliant payment solutions. It also underscores the company's continued momentum in the healthcare financial services sector and its ability to capitalize on growth opportunities with speed and efficiency.
Forward-Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
About Paysign
Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, financial technology products and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality, and retail. Built on the foundation of a reliable payments platform, Paysign's end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. Paysign's solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit paysign.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SolasCure receives FDA Fast Track Designation for Aurase Wound Gel to treat calciphylaxis ulcers
SolasCure receives FDA Fast Track Designation for Aurase Wound Gel to treat calciphylaxis ulcers

Business Wire

time30 minutes ago

  • Business Wire

SolasCure receives FDA Fast Track Designation for Aurase Wound Gel to treat calciphylaxis ulcers

CAMBRIDGE, England--(BUSINESS WIRE)--SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation for its investigational Aurase Wound Gel (AWG), in the treatment of patients with calciphylaxis ulcers. The designation recognises the potential of AWG in the treatment of this new indication, widening its application in the healing of chronic wounds whilst expediting the speed at which the new therapy could be available to patients. Calciphylaxis is a rare but serious condition involving the calcification of small blood vessels in the fat and skin tissues. It leads to blood clots, painful skin ulcers, and can progress to severe infections and sepsis. Although most commonly associated with end-stage renal disease, the condition can also occur in individuals with normal kidney function. With limited treatment options and a high one-year mortality rate 123, AWG offers an alternative debridement solution that potentially reduces the risk of infection and sepsis, opening up treatment options for patients previously considered too fragile to receive the current standard of care and improving outcomes in this vulnerable population. AWG is a hydrogel releasing Tarumase, a recombinant enzyme originally isolated from medical maggots, which selectively targets fibrin, collagen and elastin in wounds to promote healing through debridement and wound bed preparation. It is currently in Phase II Clinical trials for the treatment of venous leg ulcers, having established proof-of-concept, a strong safety profile and pain-free application 4. David Fairlamb, Chief Development Officer at SolasCure said: 'Given the unmet medical need and the poor outcomes for patients with calciphylaxis, the FDA's granting Fast Track Designation is a significant milestone. Not only does it reflect the promise of Aurase Wound Gel in the treatment of calciphylaxis ulcers, but it also adds a new indication, increasing its potential to help more patients, therefore opening up an even larger target market for SolasCure.' For more information about SolasCure, please visit:

US stock futures higher as Israel-Iran conflict spikes oil prices
US stock futures higher as Israel-Iran conflict spikes oil prices

USA Today

time30 minutes ago

  • USA Today

US stock futures higher as Israel-Iran conflict spikes oil prices

US stock futures higher as Israel-Iran conflict spikes oil prices Show Caption Hide Caption Global oil prices spike after Israeli strike on Iran Global oil prices surged after Israel launched a strike on Iran, escalating fears of wider conflict in the Middle East. unbranded - Newsworthy U.S. stock futures are higher even as fighting between Israel and Iran spiked oil prices. Futures linked to the blue-chip Dow rose 0.36%, while broad S&P 500 futures added 0.42% and tech-heavy Nasdaq futures gained 0.49%. Oil prices extended gains after Israel temporarily knocked out a natural gas processing facility and targeted fuel storage tanks during strikes over the weekend as part of its campaign against Tehran's nuclear program. Oil jumped by the most in three years late last week when Israel first attacked Iran and Iran fired back. Iran is considering shutting down the Strait of Hormuz, a senior commander said, but analysts were skeptical this would happen. "The closure of Hormuz is a low-risk event as Iran would be damaging its own position, both economically and politically, by irritating its main customer," said Natasha Kaneva, head of global commodities research at JP Morgan, in a note late last main players in the Middle East have strong incentives to keep the conflict contained given the economic transformation currently planned and implemented in the Gulf region requires a sustained absence of conflict." Separtely, President Donald Trump warned Iran not to touch U.S. targets or else it could face the "full strength and might" of the American military. Oil prices, inflation and the Fed If the Israel-Iran conflict causes oil prices to continue surging, inflation will jump and consumers will pay the price. The price of oil makes up about half the price of a gallon of gas, so one of the first things to be affected by rising oil prices would be prices at the pump. But oil also affects the cost of producing things and transporting them to your local store, so even consumers who don't drive or use public transportation will eventually feel the squeeze of more expensive oil one way or another. The threat of inflation will likely keep the Federal Reserve on hold, economists said. Almost no one forecasts a rate cut when the Fed wraps up its two-day policy meeting mid-week, according to the CME Fed Watch tool that tracks the odds the market puts on a rate move at each Fed meeting. Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@ and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday.

TotalEnergies Expands Malaysia's Portfolio Strengthening its Strategic Partnership with PETRONAS
TotalEnergies Expands Malaysia's Portfolio Strengthening its Strategic Partnership with PETRONAS

Business Wire

time30 minutes ago

  • Business Wire

TotalEnergies Expands Malaysia's Portfolio Strengthening its Strategic Partnership with PETRONAS

PARIS--(BUSINESS WIRE)-- On the occasion of Energy Asia 2025 in Kuala Lumpur, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) announces the acquisition from PETRONAS of interests in multiple blocks offshore Malaysia and in one block offshore Indonesia, where exploration, appraisal and development programs will be progressed. The licenses, which are all in different maturation stages, cover more than 100,000 km2. TotalEnergies will notably hold, alongside PETRONAS through its wholly-owned subsidiary Petronas Carigali Sdn Bhd, a 50% operated working interest in Blocks SK301b and SK313, where significant gas discoveries (more than 4 Tcf) were made and are expected to be developed to support gas supply to Malaysia LNG from 2030. TotalEnergies will also hold, alongside PETRONAS, interests in several exploration blocks offshore Malaysia. The transaction is subject to customary conditions, including regulatory approvals. Following the SapuraOMV's acquisition in December 2024, this transaction strengthens TotalEnergies' position in South-East Asia with Malaysia as an anchor point, in partnership with PETRONAS. Building on the successful and long-standing collaboration between the two companies in the upstream business across several countries, Patrick Pouyanné, Chairman and CEO of TotalEnergies and Tan Sri Tengku Muhammad Taufik, President and Group CEO of PETRONAS, also signed a strategic cooperation agreement to deepen their partnership in exploration and production businesses globally. "TotalEnergies has established itself as a significant gas producer in Malaysia. We are pleased to further expand our presence in the country, which we see as a strategic platform for our future low-cost, low-carbon production and cash-flow growth, underpinned by the exposure to Asian LNG market. TotalEnergies and PETRONAS strategic collaboration, which extends well beyond Malaysia through our multiple joint ventures worldwide, enables us to access a large and diverse portfolio in the country, spanning from exploration to production", said Patrick Pouyanné, Chairman and CEO of TotalEnergies. 'For a long time, PETRONAS and TotalEnergies have demonstrated how complementary strengths can unlock new opportunities. Today's signing marks another significant step forward in our shared commitment to responsible growth and long-term value creation. Together, we will pursue and develop advantaged barrels across Malaysia's and Indonesia's frontier emerging exploration blocks. Our focus is on maximising high commercial potential while delivering sustainable value for all stakeholders", said Tan Sri Tengku Taufik, PETRONAS President and Group Chief Executive Officer. Broadening our global strategic collaboration with PETRONAS to Indonesia TotalEnergies has signed an agreement to acquire a 24.5% interest from PETRONAS in the Bobara block, offshore Indonesia, to carry out an exploration work program targeting oil prospects. After completion, TotalEnergies will hold 24.5% working interest in the Production Sharing Contract while PETRONAS will retain the remainder of the working interest and operatorship in the block. *** About TotalEnergies in Malaysia TotalEnergies has been operating in Malaysia since 1985 and is a long-standing partner of the national oil company PETRONAS. Following the completion of the acquisition of SapuraOMV Upstream, TotalEnergies is the 3rd largest gas operator in the country. The Company employs about 300 people in the country and holds operated interests of 40% in block SK408 and 30% in block SK310, as well as a 40% interest in block SB412. These interests round out its existing portfolio of 34.9% in both blocks SB-2K and SB-N and 85% in block 2E (Marjoram). Via its affiliate TotalEnergies Marketing Malaysia, TotalEnergies also markets petroleum products. In 2023, the Company signed a deal with PETRONAS and Mitsui to develop a CO 2 storage project in Southeast Asia and assess several potential sites in the Malay Basin. About TotalEnergies TotalEnergies is a global integrated energy company that produces and markets energies: oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables and electricity. Our more than 100,000 employees are committed to providing as many people as possible with energy that is more reliable, more affordable and more sustainable. Active in about 120 countries, TotalEnergies places sustainability at the heart of its strategy, its projects and its operations. @TotalEnergies TotalEnergies TotalEnergies TotalEnergies Cautionary Note The terms 'TotalEnergies', 'TotalEnergies company' or 'Company' in this document are used to designate TotalEnergies SE and the consolidated entities that are directly or indirectly controlled by TotalEnergies SE. Likewise, the words 'we', 'us' and 'our' may also be used to refer to these entities or to their employees. The entities in which TotalEnergies SE directly or indirectly owns a shareholding are separate legal entities. This document may contain forward-looking information and statements that are based on a number of economic data and assumptions made in a given economic, competitive and regulatory environment. They may prove to be inaccurate in the future and are subject to a number of risk factors. Neither TotalEnergies SE nor any of its subsidiaries assumes any obligation to update publicly any forward-looking information or statement, objectives or trends contained in this document whether as a result of new information, future events or otherwise. Information concerning risk factors, that may affect TotalEnergies' financial results or activities is provided in the most recent Universal Registration Document, the French-language version of which is filed by TotalEnergies SE with the French securities regulator Autorité des Marchés Financiers (AMF), and in the Form 20-F filed with the United States Securities and Exchange Commission (SEC). TotalEnergies Media Relations: +33 (0)1 47 44 46 99 l presse@ l @TotalEnergiesPR Investor Relations: +33 (0)1 47 44 46 46 l ir@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store